Navigation Links
American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
Date:9/3/2009

NEW YORK and BEIRUT, Sept. 3 /PRNewswire/ -- A medical team at the American University of Beirut Medical Center (AUBMC) has successfully performed the first artificial heart implant in Lebanon, saving the life of a 37-year-old man suffering from terminal heart failure.

Led by two AUB doctors, the six-hour operation, which took place on August 28, 2009, was deemed a success after the patient survived the first critical 72 hours and showed improvements in all his vital signs. The artificial heart implant operation involves the insertion of a left ventricular assist device (LVAD) that assumes the functions of the left ventricle of the heart, the dominant chamber which is responsible for pumping oxygenated blood via the aorta to the rest of the body.

"The operation was a huge success as it was this patient's last chance at life," said Dr. Pierre Sfeir, the AUBMC surgeon who conducted the operation.

"His vital organs are functioning normally and the new device implant is pumping blood properly," added Dr. Hadi Skouri, the AUBMC cardiologist who has been treating the patient and a specialist on heart failure and transplantation.

The LVAD used in this surgery, the Heartmate II, is manufactured by the US medical technology company, Thoratec.

The two AUB doctors were assisted by a multidisciplinary medical team, including a leading expert on LVAD operations, Dr. Latif Arusoglu, a German surgeon, as well as a clinical specialist, both dispatched by Thoratec.

"90 percent of all cardiac failures are the result of left ventricular failure," explained Dr. Skouri. When the left ventricle does not function adequately, there are several treatment options available to physicians, he added. As a first step, these patients are placed on a drug therapy that helps the heart pump blood. If that is not successful, patients might undergo a relatively simple operation that involves inserting a pacemaker or other devices that help improve the heart's pumping function. As a last resort, physicians opt for human heart transplants. Since human heart donors are in short supply, surgeons have previously used the LVAD as a temporary solution, while waiting for a human donor heart.

LVADs have been available to patients since the mid-1990s, but only through an in-hospital procedure. Not all patients are eligible for this expensive and complicated surgery: "If the patient suffers from other serious chronic diseases, we cannot operate," said Dr. Sfeir, who heads the Division of Cardio-thoracic Surgery at AUBMC.

Dr. Samir Alam, who heads the Cardiology Division, stressed that LVADs are a "last-resort treatment." "Although we are very excited to offer this new procedure to our patients, we cannot stress enough the complexity of this surgery and the fact that not all cardiac patients are eligible for this implant," he noted.

"I was facing death when I arrived here," said the 37-year-old father of four who was operated on at AUBMC. "Merely lifting an arm would knock the wind out of me. I could barely breathe. Now, I have a new lease on life." He added: "My family is really, really happy. My dad cannot stop smiling."

About the AUB Medical Center

AUBMC is the private, not-for-profit teaching center of the Faculty of Medicine at the American University of Beirut. It consists of a 420-bed medical center and provides all medical, surgical, pediatrics, obstetrics/gynecological and psychiatric services. The Medical Center offers comprehensive healthcare services, extensive tertiary/quaternary resources, medical, nursing, and paramedical training.

www.aubmc.org.lb

    Contact:
    Ada H. Porter, Director of Communications (USA)
    porter@aub.edu (212) 583-7618
    Ibrahim Khoury, Director of Information and Public Relations (Lebanon)
    ifkhoury@aub.edu.lb 011961350000x2670


'/>"/>
SOURCE American University of Beirut
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
2. Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options
3. New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform
4. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
5. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
6. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
7. Data From Clinical Study of bioTheranostics Molecular Diagnostic Test Presented at American Society of Clinical Oncology Annual Meeting
8. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
9. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
10. Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting
11. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
Breaking Medicine News(10 mins):